The clear mutual exclusivity of EPHA2 with the aforementioned genes at pan-cancer level are mainly due to the contribution of the Head and Neck squamous cell carcinoma tumor samples (HNSC) in which EPHA2 was found to be more frequently mutated. This evidence concerns the gene EPHA2 and cancer.